Historically, payers have accepted these factors for reasons including the fact that treatment of rare diseases represents a significant area of unmet need in healthcare and many regulatory ...

Real-world data is a vital part of rare disease drug development, but to get a true picture of patients ... and in compliance with regulatory standards. Identifying high-volume prescribers ...

ISLAMABAD: In a rare move, the National Electric Power Regulatory Authority (Nepra ... for the booster instead of disclosing the true picture. The regulator has also found Central Power Purchasing ...

Doha, Qatar: Sidra Medicine, a member of Qatar Foundation, is proud to announce its strategic partnership with the Middle ...

Q3 2024 Total Revenue of $141.5M, a 37% Increase Year-over-Year Galafold®Q3 Revenue of $120.4M, up 20% Year-over-Year PRINCETON, N.J., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: ...

Vanguard Russell 2000 Growth Index Fund ETF Shares tracks the Russell 2000 Growth Index, offering diversified exposure to U.S ...

Users could access information about their risk for certain diseases, their ancestry ... the United States until it completed the agency's regulatory review process. The company could continue ...

Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has entered into a technology collaboration and licence agreement with Berlin-based Eckert & Ziegler SE (EZAG) for ...

a rare genetic disorder, the company said at the time. "This is also the first time the FDA has granted authorization to market a direct-to-consumer genetic test, and it gives 23andMe a regulatory ...

Harmful chemicals are pervasively used in fashion production and the health effects are undeniable. What is toxic clothing?